Welcome to the Respiratory Epidemiology Group website. We are an interdisciplinary group of investigators who study the epidemiology and health outcomes of pulmonary diseases.

Director: Mark D. Eisner, MD, MPH

Our mission:

• To apply state-of-the-art epidemiologic and biostatistical methods to study health outcomes in a broad array of pulmonary diseases.
• To identify risk factors for adverse health outcomes among persons with chronic pulmonary diseases
• To translate science into policy aimed at reducing the global burden of respiratory disease

Our vision:

• To reduce the burden of chronic respiratory disease
• To decrease suffering and death from pulmonary disease

Our areas of research include:

• Development of disability in COPD
• Health outcomes in severe asthma
• Impact of environmental exposures, including secondhand smoke exposure and air pollution, on patients with obstructive lung disease
• Health care costs of obstructive lung disease
• Interaction between occupation and lung disease
  • Effect of occupational exposures on health outcomes
  • Impact of obstructive lung disease on work disability
• Biomarkers and respiratory disease outcomes
• Health outcomes of acute lung injury / Acute Respiratory Distress Syndrome
• Outcomes and disability in obstructive sleep apnea
• Health disparities in respiratory disease